Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormonal interventions for menstrual migraines.

Kathleen J Chavanu1, Dannielle C O'Donnell

  • 1Department of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, Illinois 60515, USA.

Pharmacotherapy
|November 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Illness Burden and Unmet Patient Needs in Giant Cell Arteritis: Current State and Future Prospects.

Open access rheumatology : research and reviews·2025
Same author

Paucity of Published Data and Protocols for Hypoglycemia Management in Long-term Care.

The Senior care pharmacist·2024
Same author

Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2012
Same author

Efficacy/safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertension.

Advances in therapy·2012
Same author

Efficacy/safety of olmesartan medoxomil versus losartan potassium in patients by stage 1 or 2 hypertension.

Postgraduate medicine·2012
Same author

A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension.

Postgraduate medicine·2011

Menstrual migraines pose treatment challenges, but hormonal interventions can effectively manage refractory cases. These therapies reduce migraine frequency, disability, and improve quality of life for affected women.

Area of Science:

  • Neurology
  • Endocrinology
  • Women's Health

Background:

  • Menstrual migraines present unique treatment challenges.
  • Some women experience refractory migraines despite standard therapies.
  • Distinct pathophysiology differentiates menstrual from non-menstrual migraines.

Purpose of the Study:

  • To review the effectiveness of hormonal interventions for refractory menstrual migraines.
  • To highlight the benefits of hormonal therapies in reducing migraine frequency and disability.

Main Methods:

  • Review of published studies on hormonal interventions for menstrual migraines.
  • Analysis of various hormonal treatments including oral contraceptives, estrogen therapy, SERMs, danazol, and leuprolide.

Related Experiment Videos

Main Results:

  • Hormonal interventions can significantly reduce the frequency of menstrual migraines.
  • These treatments lessen the need for acute migraine therapies.
  • Improved quality of life and decreased migraine-related disability are observed.

Conclusions:

  • Hormonal interventions are a viable option for managing refractory menstrual migraines.
  • Targeting hormonal fluctuations offers a pathway to improved patient outcomes.
  • Further research into specific hormonal strategies may optimize treatment.